These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6380747)
41. Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein. Fan H; Chute H; Chao E; Feuerman M Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5965-9. PubMed ID: 6310608 [TBL] [Abstract][Full Text] [Related]
42. The transforming gene of Moloney murine sarcoma virus. Canaani E; Robbins KC; Aaronson SA Nature; 1979 Nov; 282(5737):378-83. PubMed ID: 503218 [TBL] [Abstract][Full Text] [Related]
43. In vitro methylation of specific regions of the cloned Moloney sarcoma virus genome inhibits its transforming activity. McGeady ML; Jhappan C; Ascione R; Vande Woude GF Mol Cell Biol; 1983 Mar; 3(3):305-14. PubMed ID: 6843547 [TBL] [Abstract][Full Text] [Related]
44. Sequence of events in the transformation process in cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus. Brown RL; Horn JP; Wible L; Arlinghaus RB; Brinkley BR Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5593-7. PubMed ID: 6946495 [TBL] [Abstract][Full Text] [Related]
45. In vivo identification of the transforming gene product of simian sarcoma virus. Robbins KC; Devare SG; Reddy EP; Aaronson SA Science; 1982 Dec; 218(4577):1131-3. PubMed ID: 6293053 [TBL] [Abstract][Full Text] [Related]
46. Biological and molecular biological characterization of the virus progeny from transformed clones MuSV-124 and MuSV-349: evidence for MuLV-specific nucleotide sequences in the MoMuSV size class of RNA from MoMuSV-124. Dekaban GA; Ball JK; Loosmore SM; McCarter JA J Gen Virol; 1980 Apr; 47(2):407-22. PubMed ID: 6245178 [TBL] [Abstract][Full Text] [Related]
47. A defined subgenomic fragment of in vitro synthesized Moloney sarcoma virus DNA can induce cell transformation upon transfection. Andersson P; Goldfarb MP; Weinberg RA Cell; 1979 Jan; 16(1):63-75. PubMed ID: 84715 [TBL] [Abstract][Full Text] [Related]
48. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf. Topol LZ; Marx M; Calothy G; Blair DG Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484 [TBL] [Abstract][Full Text] [Related]
49. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus. Stocking C; Kollek R; Bergholz U; Ostertag W Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5746-50. PubMed ID: 2994046 [TBL] [Abstract][Full Text] [Related]
52. Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation. Freeman RS; Donoghue DJ Mol Cell Biol; 1989 Sep; 9(9):4087-90. PubMed ID: 2528689 [TBL] [Abstract][Full Text] [Related]
53. Isolation and partial characterization of a 55,000-dalton protein induced in cells transformed by the ml strain of Moloney murine sarcoma virus. Wood TG; Somers K; Arlinghaus RB Virology; 1980 Aug; 105(1):148-58. PubMed ID: 6251602 [No Abstract] [Full Text] [Related]
54. Moloney leukemia virus immortalizes B lymphocytes in vitro. Runnels J; Serunian L; Thursby M; Rosenberg N J Virol; 1991 Oct; 65(10):5549-52. PubMed ID: 1895405 [TBL] [Abstract][Full Text] [Related]
55. Molecular cloning and chromosomal mapping of a human locus related to the transforming gene of Moloney murine sarcoma virus. Prakash K; McBride OW; Swan DC; Devare SG; Tronick SR; Aaronson SA Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5210-4. PubMed ID: 6291031 [TBL] [Abstract][Full Text] [Related]
56. Biological, immunological, and molecular properties of revertants of cat cells transformed by murine sarcoma virus. Fischinger PJ; Blevins CS; Frankel AE; Tuttle-Fuller N; Haapala DK; Nomura S; Robey WG Cancer Res; 1981 Mar; 41(3):958-65. PubMed ID: 6257388 [No Abstract] [Full Text] [Related]
57. Binding of retrovirus-associated protein kinase and proteins to Staphylococcus aureus. Kloetzer WS; Arlinghaus RB J Gen Virol; 1982 Jun; 60(Pt 2):365-70. PubMed ID: 6955449 [TBL] [Abstract][Full Text] [Related]
58. The myeloproliferative sarcoma virus retains transforming functions after introduction of a dominant selectable marker gene. Ostertag W; Seliger B; Kollek R; Stocking C; Bergholz U; Smadja-Joffe F J Gen Virol; 1986 Jul; 67 ( Pt 7)():1361-71. PubMed ID: 3014049 [TBL] [Abstract][Full Text] [Related]
59. Identification of an autoinhibitory region in the activation loop of the Mos protein kinase. Robertson SC; Donoghue DJ Mol Cell Biol; 1996 Jul; 16(7):3472-9. PubMed ID: 8668163 [TBL] [Abstract][Full Text] [Related]
60. Molecular cloning and characterization of a cDNA showing negative regulation in v-src-transformed 3Y1 rat fibroblasts. Ozaki T; Sakiyama S Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2593-7. PubMed ID: 8385338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]